在摩洛哥人口中对癌症知识,态度和行为的集群分析
Mohamed Khalis1,2,3,4, Imad Elbadisy5,6, Oumnia Bouaddi5,6
1Department of Public Health, Mohammed VI Center for Research and Innovation, Rabat, Morocco. mkhalis@um6ss.ma.
BMC cancer
|June 2, 2024
概括
在摩洛哥的中年农村妇女中,癌症预防知识和态度最低. 需要有针对性的干预措施来改善理解和加强癌症控制策略.
科学领域:
- 公共卫生 公共卫生
- 癌症预防研究 癌症预防研究
- 健康行为研究 研究健康行为研究
背景情况:
- 癌症对全球健康构成重大挑战,导致大量的发病率,死亡率和经济负担.
- 大约40%的癌症病例是可以预防的,这凸显了对有效预防策略的迫切需要.
- 了解公众的知识,态度和做法对于制定有针对性的癌症预防活动至关重要.
研究的目的:
- 评估卡萨布兰卡 (摩洛哥) 成年患者的癌症预防知识,态度和实践.
- 确定与不同程度的癌症预防意识相关的特征.
- 为制定量身定制的癌症预防政策和干预措施提供信息.
主要方法:
- 在摩洛哥卡萨布兰卡的两家医院对成年患者进行了横截面调查.
- 数据是通过面对面的问卷收集的,受过培训的面试官用当地语言进行面试.
- 一种无监督的集群方法分析了17个变量,包括人口统计和健康感知,以评估癌症态度和知识分数.
主要成果:
- 集群分析根据知识和态度得分确定了不同的群体.
- 集群1的参与者表现出最高的平均态度 (13.9 ± 2.15) 和知识水平 (50.8%).
- 集群3的参与者具有最低的态度 (9.48±2.02) 和知识水平 (7.5%),以农村中年女性为特征,对卫生专业人员的信息依赖有限.
结论:
- 农村地区的女性,特别是中年人群和那些不太可能咨询卫生专业人员的人群,癌症知识和态度最低.
- 这些已识别的子组是定制干预措施的关键目标,以提高癌症意识.
- 这些发现支持通过有针对性的教育举措加强摩洛哥的癌症预防和控制战略.
相关概念视频
01:21Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
02:16Surveys
14.7K
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
14.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:12What is Cancer?
10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:20Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177